Back to Search
Start Over
Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis.
- Source :
-
Pharmacological research [Pharmacol Res] 2021 Nov; Vol. 173, pp. 105882. Date of Electronic Publication: 2021 Sep 13. - Publication Year :
- 2021
-
Abstract
- Doxorubicin is an effective chemotherapeutic drug, but causes cardiotoxicity which limits its use. Oxidative stress, mitochondrial dysfunction, and inflammation are closely implicated in doxorubicin-induced cardiotoxicity (DIC). Necroptosis, a new form of programmed cell death, was also upregulated by doxorubicin, leading to cardiomyocyte death and cardiac dysfunction. Donepezil, an acetylcholinesterase inhibitor, exerted cardioprotection against various heart diseases. However, its cardioprotective effects in DIC are still unknown. We hypothesized that donepezil reduces reactive oxygen species (ROS) production, mitochondrial dysfunction, mitochondrial dynamics imbalance, necroptosis, and apoptosis in DIC rats. Male Wistar rats were assigned to receive either normal saline solution (n = 8) or doxorubicin (3 mg/kg, 6 doses, n = 16) via intraperitoneal injection. The doxorubicin-treated rats were further subdivided to receive either sterile drinking water (n = 8) or donepezil (5 mg/kg/day, p.o., n = 8) for 30 days. At the end of the experiment, the left ventricular (LV) function was determined. Serum and heart tissue were collected to evaluate histological and biochemical parameters. Doxorubicin-treated rats exhibited higher levels of inflammatory cytokines and ROS production. Doxorubicin also impaired mitochondrial function, mitochondrial dynamics balance, mitophagy, and autophagy, which culminated in apoptosis. Furthermore, doxorubicin increased necroptosis as evidenced by increased phosphorylation of receptor-interacting protein kinase 1, receptor-interacting protein kinase 3, and mixed-lineage kinase domain-like. All of these mechanisms led to LV dysfunction. Interestingly, donepezil alleviated mitochondrial injury, mitophagy, autophagy, and cardiomyocyte death, leading to improved LV function in DIC. In conclusion, donepezil attenuated DIC-induced LV dysfunction by reducing mitochondrial damage, mitophagy, autophagy, apoptosis, and necroptosis.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Subjects :
- Animals
Apoptosis drug effects
Autophagy drug effects
Cardiotoxicity metabolism
Cardiotoxicity physiopathology
Cell Line
Cholinesterase Inhibitors pharmacology
Donepezil pharmacology
Male
Mitochondria, Heart drug effects
Mitochondria, Heart metabolism
Mitochondrial Dynamics drug effects
Myocardium metabolism
Necroptosis drug effects
Protein Kinases metabolism
Rats, Wistar
Reactive Oxygen Species metabolism
Receptor-Interacting Protein Serine-Threonine Kinases metabolism
Ventricular Function, Left drug effects
Rats
Antibiotics, Antineoplastic
Cardiotoxicity drug therapy
Cholinesterase Inhibitors therapeutic use
Donepezil therapeutic use
Doxorubicin
Subjects
Details
- Language :
- English
- ISSN :
- 1096-1186
- Volume :
- 173
- Database :
- MEDLINE
- Journal :
- Pharmacological research
- Publication Type :
- Academic Journal
- Accession number :
- 34530122
- Full Text :
- https://doi.org/10.1016/j.phrs.2021.105882